PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24970286 ↗2014Reported benefit

Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.

RatSpinal cord injuryContusionSprague-Dawleyn = 48 rats total, 16 per group; 8 per group for biochemistry a…Intraperitoneal2 mg/kg body weight (methylprednisolone comparator 30 mg/kg…First dose 30 min after injury

Model: Acute spinal cord injury by Allen's weight-drop method, 7 g x 3 cm extradural impact at spinal segment T11

Both meglumine cyclic adenylate and methylprednisolone groups showed higher cAMP concentrations and adenylate cyclase 3 activity, lower phosphodiesterase 4D activity at the lesion site and better behavioural scores than saline controls (P<0.05). cAMP was higher with meglumine cyclic adenylate than…

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.